Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility

被引:575
作者
Barber, PA [1 ]
Zhang, J [1 ]
Demchuk, AM [1 ]
Hill, MD [1 ]
Buchan, AM [1 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada
关键词
D O I
10.1212/WNL.56.8.1015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Thrombolytic therapy for acute stroke (<3 hours) will not have a major impact on death and dependency unless it is accessible to more patients, Objective: To determine why patients with ischemic stroke did not receive TV TPA and assess the availability of this therapy to patients with ischemic stroke. Methods: Consecutive patients with acute ischemic stroke were prospectively identified at a university teaching hospital between October 1996 and December 1999. Additional patients with ischemic stroke were identified that were admitted to one of three other hospitals in the Calgary region during the study period. The Oxford Community Stroke Programme Classification was used to record type and side of stroke. Results: Of 2165 stroke patients presenting to the university hospital, 1168 (53.9%) were diagnosed with ischemic stroke, 31.8% with intracranial hemorrhage (intracerebral, subarachnaid, or subdural), and 13.9% with TIA. Delay in presentation to emergency department beyond 3 hours excluded 73.1% (854/1168). Major reasons for delay included uncertain time of onset (24.2%). patients waited to see if symptoms would improve (29%), delay caused by transfer fr om an outlying hospital (8.9%), and inaccessibility of treating hospital (5.7%). Twenty-seven percent of patients with ischemic stroke (314/1168) were admitted within 3 hours of symptom onset and of these 84 (26.7%) patients received IV TPA. The major reasons for exclusion in this group of patients (<3 hours) were mild stroke (13.1%), clinical improvement (18.2%), perceived protocol exclusions (13.6%), emergency department referral delay (8.9%), and significant comorbidity (8.3%). Of those patients who were considered too mild or were documented to have had significant improvement, 32% either remained dependent at hospital discharge or died during hospital admission. Throughout the region there was a total of 1806 ischemic stroke patients (admitted to all four Calgary hospitals). During this study period, 4.7% received IV TPA. Conclusions: The majority of patients are unable to receive TPA for acute ischemic stroke because they do no not reach the hospital soon enough. Of those patients presenting within 3 hours, 27% received the therapy but a further 31% were excluded because their symptoms were either considered too mild or were rapidly improving. Subsequently, a third of these patients were left either dependent or dead, bringing into question the initial decision not to treat.
引用
收藏
页码:1015 / 1020
页数:6
相关论文
共 27 条
  • [1] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study
    Albers, GW
    Bates, VE
    Clark, WM
    Bell, R
    Verro, P
    Hamilton, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1145 - 1150
  • [3] ALEXANDROV AV, 2000, STROKE, V10, P27
  • [4] Limitations of clinical diagnosis in acute stroke
    Allder, SJ
    Moody, AR
    Martel, AL
    Morgan, PS
    Delay, GS
    Gladman, JR
    Fentem, P
    Lennox, GG
    [J]. LANCET, 1999, 354 (9189) : 1523 - 1523
  • [5] CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION
    BAMFORD, J
    SANDERCOCK, P
    DENNIS, M
    BURN, J
    WARLOW, C
    [J]. LANCET, 1991, 337 (8756) : 1521 - 1526
  • [6] Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
    Barber, PA
    Demchuk, AM
    Zhang, JJ
    Buchan, AM
    [J]. LANCET, 2000, 355 (9216) : 1670 - 1674
  • [7] TREATMENT OF ACUTE ISCHEMIC STROKE - CHALLENGING THE CONCEPT OF A RIGID AND UNIVERSAL TIME WINDOW
    BARON, JC
    VONKUMMER, R
    DELZOPPO, GJ
    [J]. STROKE, 1995, 26 (12) : 2219 - 2221
  • [8] Effectiveness of t-PA in acute ischemic stroke - Outcome relates to appropriateness
    Buchan, AM
    Barber, PA
    Newcommon, N
    Karbalai, HG
    Demchuk, AM
    Hoyte, KM
    Klein, GM
    Feasby, TE
    [J]. NEUROLOGY, 2000, 54 (03) : 679 - 684
  • [9] Buchan AM, 2000, CAN MED ASSOC J, V162, P47
  • [10] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial
    Furlan, A
    Higashida, R
    Wechsler, L
    Gent, M
    Rowley, H
    Kase, C
    Pessin, M
    Ahuja, A
    Callahan, F
    Clark, WM
    Silver, F
    Rivera, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2003 - 2011